Loss of α-gal during primate evolution enhanced antibody-effector function and resistance to bacterial sepsis
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Cell Host & Microbe
- Vol. 29 (3) , 347-361.e12
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Bill and Melinda Gates Foundation (5723/2014, FEDER029411, OPP1148170)
- Baylor College of Medicine
- University of California, San Diego
- University of Alabama
- Center for Sepsis Control and Care
- National Science Foundation (274/2016, HR18-00502)
- Bundesministerium für Forschung, Technologie und Raumfahrt (01EO1502, UIDB/00276/2020)
- Fundação Luso-Americana para o Desenvolvimento
- Universitätsklinikum Jena
- Deutsche Forschungsgemeinschaft (EXS 2051, WE 4971/6-1)
- Fundação para a Ciência e a Tecnologia (SFRH/BD/52177/2013, SFRH/BPD/112135/2015)
This publication has 83 references indexed in Scilit:
- Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient miceJournal of Experimental Medicine, 2012
- IgA is important for clearance and critical for protection from rotavirus infectionMucosal Immunology, 2012
- Sexual selection by female immunity against paternal antigens can fix loss of function allelesProceedings of the National Academy of Sciences, 2011
- FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivoProceedings of the National Academy of Sciences, 2010
- UniFrac: an effective distance metric for microbial community comparisonThe ISME Journal, 2010
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010
- Immunodesign of experimental sepsis by cecal ligation and punctureNature Protocols, 2008
- Identification of a GH110 Subfamily of α1,3-GalactosidasesJournal of Biological Chemistry, 2008
- The Galα1,3Galβ1,4GlcNAc-R (α-Gal) epitope: A carbohydrate of unique evolution and clinical relevanceBiochimica et Biophysica Acta (BBA) - General Subjects, 2008
- Agalactosylated IgG antibodies depend on cellular Fc receptors forin vivoactivityProceedings of the National Academy of Sciences, 2007